Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial : The Lancet Oncology
Links shared publicly online about this topic.
- 858total visits
Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial : The Lancet Oncology
Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 random...
View full resource at thelancet.com
Tags: Cancer, Breast Cancer, Phase 3 Clinical Trial, Women's Health, Oncology
Most Recently Shared on September 21, 2010 at 9:16 am By:
Does SLN resection in patients with breast cancer achieve the same survival and regional control as ALND? http://bit.ly/cbmIT7
Advertisement
